Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice.
Ioannis MerinopoulosTharusha GunawardenaNatasha CorballisU BhalraamTim GilbertClint MaartPaul RichardsonAlisdair RydingToomas SarevChris SawhSreekumar SulfiUpul WickramarachchiTrevor WistowMohamed O MohamedMamas A MamasVassilios S VassiliouSimon C EccleshallPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2022)
DCB-only angioplasty, for stable angina and predominantly large vessels, is safe compared to DES as part of routine clinical practice, in terms of all-cause mortality and MACE, including unplanned TLR.
Keyphrases
- clinical practice
- coronary artery disease
- percutaneous coronary intervention
- toll like receptor
- cardiovascular events
- coronary artery bypass grafting
- inflammatory response
- patients undergoing
- immune response
- coronary artery
- heart failure
- emergency department
- acute coronary syndrome
- nuclear factor
- left ventricular